BioSpace News Archive

Sheila Gujrathi, M.D. will join the board of directors as executive chair, while Jörn Drappa, M.D., Ph.D. will serve as chief medical officer.

It is the largest venture capital fund in Europe focused on the life sciences.

Veru Inc. today announced that updated clinical data from the positive Phase 1b/2 study of sabizabulin (VERU-111)

Todos Medical, Ltd. (OTCQB: TOMDF), a medical diagnostics and solutions company with comprehensive product offerings, today announced it has received a notice of allowance from the US Patent & Trademark Office (USPTO) for a trademark covering the Company’s proprietary 3CL protease inhibitor oral antiviral drug candidate NLC-V-01, also known as Tollovir™.

Lyndra Therapeutics today announced the appointment of two new members of its Board of Directors: Doug Dachille, former Chief Investment Officer of American International Group, Inc.

Xilis, Inc. announced today the presentation of data on the company’s proprietary MOS technology. Data were presented at the 2021 European Society for Medical Oncology (ESMO) Congress in an oral presentation and two poster presentations.

Gilead Sciences, Inc. (Nasdaq: GILD) today announced the upcoming presentation of new data from the company’s virology research and development programs at the virtual IDWeek 2021 conference, taking place September 29 – October 3.

Humacyte, Inc. today announced the issuance of three additional U.S. patents covering its proprietary technology platform.

Partner Therapeutics, Inc. (PTx) announced a collaboration with the Biomedical Advanced Research and Development Authority ( BARDA ) to advance a new diagnostic approach to select immunoparalyzed sepsis patients that could benefit most from Leukine (sargramostim).

Neurolign™, a leader in clinical eye tracking and neuro-functional diagnostic testing, announced today the launch of NeurolignFit™ – a new consumer health and wellness device that uses professional eye-tracking technology to allow users to track, understand, and improve their overall mental acuity from the comfort of their own home